# Andersons, Inc.: financial statements, quarterly

ANDE · Nasdaq · CIK 821026 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ande.md) · [Financials](/companies/ande/financials.md) · [Filings](/companies/ande/filings.md) · [Insiders](/companies/ande/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ande/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [688](/filings/0000821026-23-000218.md) | [(770) d](/filings/0000821026-26-000010.md) | [341](/filings/0000821026-25-000112.md) | [493](/filings/0000821026-25-000150.md) | [232](/filings/0000821026-25-000204.md) | [338 d](/filings/0000821026-26-000010.md) | [371](/filings/0000821026-26-000070.md) | [535](/filings/0000821026-26-000122.md) | [296](/filings/0000821026-25-000204.md) | [330 d](/filings/0000821026-26-000010.md) | [379](/filings/0000821026-26-000070.md) | [555](/filings/0000821026-26-000122.md) |
| Cost of revenue | $m | [3,478](/filings/0000821026-24-000227.md) | [2,995 d](/filings/0000821026-26-000010.md) | [2,590](/filings/0000821026-25-000112.md) | [2,620](/filings/0000821026-25-000150.md) | [2,444](/filings/0000821026-25-000204.md) | [2,910 d](/filings/0000821026-26-000010.md) | [2,506](/filings/0000821026-26-000070.md) | [2,977](/filings/0000821026-26-000122.md) | [2,507](/filings/0000821026-25-000204.md) | [2,305 d](/filings/0000821026-26-000010.md) | [2,467](/filings/0000821026-26-000070.md) | [2,874](/filings/0000821026-26-000122.md) |
| Gross profit | $m | [158](/filings/0000821026-24-000227.md) | [218 d](/filings/0000821026-26-000010.md) | [128](/filings/0000821026-25-000112.md) | [175](/filings/0000821026-25-000150.md) | [177](/filings/0000821026-25-000204.md) | [213 d](/filings/0000821026-26-000010.md) | [153](/filings/0000821026-26-000070.md) | [158](/filings/0000821026-26-000122.md) | [171](/filings/0000821026-25-000204.md) | [231 d](/filings/0000821026-26-000010.md) | [161](/filings/0000821026-26-000070.md) | [224](/filings/0000821026-26-000122.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.9](/filings/0000821026-24-000227.md) | [13.3 d](/filings/0000821026-26-000010.md) | [1.3](/filings/0000821026-25-000112.md) | [4.9](/filings/0000821026-25-000150.md) | [10.7](/filings/0000821026-25-000204.md) | [13.1 d](/filings/0000821026-26-000010.md) | [(2.1)](/filings/0000821026-26-000070.md) | [8.0](/filings/0000821026-26-000122.md) | [(0.2)](/filings/0000821026-25-000204.md) | [16.5 d](/filings/0000821026-26-000010.md) | [4.6](/filings/0000821026-26-000070.md) | [13.4](/filings/0000821026-26-000122.md) |
| Net income | $m | [9.7](/filings/0000821026-24-000227.md) | [51.2 d](/filings/0000821026-26-000010.md) | [5.6](/filings/0000821026-25-000112.md) | [36.0](/filings/0000821026-25-000150.md) | [27.4](/filings/0000821026-25-000204.md) | [45.1 d](/filings/0000821026-26-000010.md) | [0.3](/filings/0000821026-26-000070.md) | [7.9](/filings/0000821026-26-000122.md) | [20.1](/filings/0000821026-25-000204.md) | [67.4 d](/filings/0000821026-26-000010.md) | [33.2](/filings/0000821026-26-000070.md) | [56.6](/filings/0000821026-26-000122.md) |
| Diluted EPS | $ per share | [0.28](/filings/0000821026-24-000227.md) | not reported | [0.16](/filings/0000821026-25-000112.md) | [1.05](/filings/0000821026-25-000150.md) | [0.80](/filings/0000821026-25-000204.md) | not reported | [0.01](/filings/0000821026-26-000070.md) | [0.23](/filings/0000821026-26-000122.md) | [0.59](/filings/0000821026-25-000204.md) | not reported | [0.97](/filings/0000821026-26-000070.md) | [1.65](/filings/0000821026-26-000122.md) |
| Basic EPS | $ per share | [0.29](/filings/0000821026-24-000227.md) | not reported | [0.16](/filings/0000821026-25-000112.md) | [1.06](/filings/0000821026-25-000150.md) | [0.80](/filings/0000821026-25-000204.md) | not reported | [0.01](/filings/0000821026-26-000070.md) | [0.23](/filings/0000821026-26-000122.md) | [0.59](/filings/0000821026-25-000204.md) | not reported | [0.98](/filings/0000821026-26-000070.md) | [1.66](/filings/0000821026-26-000122.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [644](/filings/0000821026-25-000050.md) | not reported | not reported | not reported | [562](/filings/0000821026-26-000010.md) | not reported | not reported | not reported | [98.3](/filings/0000821026-26-000010.md) | not reported | not reported |
| Current assets | $m | [2,527](/filings/0000821026-24-000227.md) | [2,807](/filings/0000821026-25-000050.md) | [2,214](/filings/0000821026-25-000112.md) | [2,249](/filings/0000821026-25-000150.md) | [2,331](/filings/0000821026-25-000204.md) | [2,850](/filings/0000821026-26-000010.md) | [2,529](/filings/0000821026-26-000070.md) | [2,175](/filings/0000821026-26-000122.md) | [1,961](/filings/0000821026-25-000204.md) | [2,376](/filings/0000821026-26-000122.md) | [2,557](/filings/0000821026-26-000070.md) | [2,082](/filings/0000821026-26-000122.md) |
| Total assets | $m | [3,588](/filings/0000821026-24-000227.md) | [3,855](/filings/0000821026-26-000010.md) | [3,261](/filings/0000821026-25-000112.md) | [3,300](/filings/0000821026-25-000150.md) | [3,388](/filings/0000821026-25-000204.md) | [4,121](/filings/0000821026-26-000010.md) | [3,798](/filings/0000821026-26-000070.md) | [3,446](/filings/0000821026-26-000122.md) | [3,297](/filings/0000821026-25-000204.md) | [3,713](/filings/0000821026-26-000122.md) | [3,920](/filings/0000821026-26-000070.md) | [3,474](/filings/0000821026-26-000122.md) |
| Current liabilities | $m | [1,408](/filings/0000821026-24-000227.md) | [1,636](/filings/0000821026-25-000050.md) | [1,083](/filings/0000821026-25-000112.md) | [1,085](/filings/0000821026-25-000150.md) | [1,178](/filings/0000821026-25-000204.md) | [1,731](/filings/0000821026-26-000010.md) | [1,434](/filings/0000821026-26-000070.md) | [1,081](/filings/0000821026-26-000122.md) | [1,330](/filings/0000821026-25-000204.md) | [1,686](/filings/0000821026-26-000122.md) | [1,871](/filings/0000821026-26-000070.md) | [1,379](/filings/0000821026-26-000122.md) |
| Total liabilities | $m | [2,139](/filings/0000821026-24-000227.md) | [2,339](/filings/0000821026-25-000050.md) | [1,785](/filings/0000821026-25-000112.md) | [1,780](/filings/0000821026-25-000150.md) | [1,865](/filings/0000821026-25-000204.md) | [2,521](/filings/0000821026-26-000010.md) | [2,203](/filings/0000821026-26-000070.md) | [1,836](/filings/0000821026-26-000122.md) | [2,074](/filings/0000821026-25-000204.md) | [2,423](/filings/0000821026-26-000122.md) | [2,610](/filings/0000821026-26-000070.md) | [2,117](/filings/0000821026-26-000122.md) |
| Long-term debt | $m | [570](/filings/0000821026-24-000227.md) | [563](/filings/0000821026-25-000050.md) | [556](/filings/0000821026-25-000112.md) | [549](/filings/0000821026-25-000150.md) | [543](/filings/0000821026-25-000204.md) | [608](/filings/0000821026-26-000010.md) | [588](/filings/0000821026-26-000070.md) | [578](/filings/0000821026-26-000122.md) | [569](/filings/0000821026-25-000204.md) | [560](/filings/0000821026-26-000122.md) | [569](/filings/0000821026-26-000070.md) | [563](/filings/0000821026-26-000122.md) |
| Current portion of debt | $m | [27.5](/filings/0000821026-24-000227.md) | [27.6](/filings/0000821026-25-000050.md) | [27.6](/filings/0000821026-25-000112.md) | [27.7](/filings/0000821026-25-000150.md) | [27.7](/filings/0000821026-25-000204.md) | [36.1](/filings/0000821026-26-000010.md) | [62.7](/filings/0000821026-26-000070.md) | [64.2](/filings/0000821026-26-000122.md) | [63.9](/filings/0000821026-25-000204.md) | [63.4](/filings/0000821026-26-000122.md) | [23.5](/filings/0000821026-26-000070.md) | [22.9](/filings/0000821026-26-000122.md) |
| Short-term borrowings | $m | [14.1](/filings/0000821026-24-000227.md) | [43.1](/filings/0000821026-24-000227.md) | [10.1](/filings/0000821026-25-000112.md) | [4.0](/filings/0000821026-25-000150.md) | [14.7](/filings/0000821026-25-000204.md) | [167](/filings/0000821026-25-000204.md) | [223](/filings/0000821026-26-000070.md) | [104](/filings/0000821026-26-000122.md) | [141](/filings/0000821026-25-000204.md) | [249](/filings/0000821026-26-000122.md) | [717](/filings/0000821026-26-000070.md) | [314](/filings/0000821026-26-000122.md) |
| Shareholders' equity | $m | [1,241](/filings/0000821026-24-000227.md) | [1,283](/filings/0000821026-25-000050.md) | [1,280](/filings/0000821026-25-000112.md) | [1,311](/filings/0000821026-25-000150.md) | [1,329](/filings/0000821026-25-000204.md) | [1,366](/filings/0000821026-26-000010.md) | [1,356](/filings/0000821026-26-000070.md) | [1,364](/filings/0000821026-26-000122.md) | [1,181](/filings/0000821026-25-000204.md) | [1,245](/filings/0000821026-26-000122.md) | [1,269](/filings/0000821026-26-000070.md) | [1,319](/filings/0000821026-26-000122.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [489 d](/filings/0000821026-24-000227.md) | [251 d](/filings/0000821026-26-000010.md) | [(240)](/filings/0000821026-25-000112.md) | [304 d](/filings/0000821026-25-000150.md) | [(2.1) d](/filings/0000821026-25-000204.md) | [269 d](/filings/0000821026-26-000010.md) | [(350)](/filings/0000821026-26-000070.md) | [299 d](/filings/0000821026-26-000122.md) | [234 d](/filings/0000821026-25-000204.md) | [(6.2) d](/filings/0000821026-26-000010.md) | [(394)](/filings/0000821026-26-000070.md) | [488 d](/filings/0000821026-26-000122.md) |
| Capital expenditure | $m | [33.7 d](/filings/0000821026-24-000227.md) | [41.7 d](/filings/0000821026-26-000010.md) | [26.8](/filings/0000821026-25-000112.md) | [28.6 d](/filings/0000821026-25-000150.md) | [37.8 d](/filings/0000821026-25-000204.md) | [56.0 d](/filings/0000821026-26-000010.md) | [46.5](/filings/0000821026-26-000070.md) | [48.8 d](/filings/0000821026-26-000122.md) | [66.8 d](/filings/0000821026-25-000204.md) | [70.9 d](/filings/0000821026-26-000010.md) | [51.7](/filings/0000821026-26-000070.md) | [75.6 d](/filings/0000821026-26-000122.md) |
| Dividends paid | $m | [6.2 d](/filings/0000821026-24-000227.md) | [6.6 d](/filings/0000821026-26-000010.md) | [6.5](/filings/0000821026-25-000112.md) | [6.5 d](/filings/0000821026-25-000150.md) | [6.5 d](/filings/0000821026-25-000204.md) | [6.8 d](/filings/0000821026-26-000010.md) | [6.7](/filings/0000821026-26-000070.md) | [6.7 d](/filings/0000821026-26-000122.md) | [6.5 d](/filings/0000821026-25-000204.md) | [7.0 d](/filings/0000821026-26-000010.md) | [6.8](/filings/0000821026-26-000070.md) | [6.8 d](/filings/0000821026-26-000122.md) |
| Share repurchases | $m | [0.0 d](/filings/0000821026-23-000218.md) | [0.0 d](/filings/0000821026-26-000010.md) | not reported | not reported | not reported | [2.3 d](/filings/0000821026-26-000010.md) | not reported | not reported | [14.2 d](/filings/0000821026-25-000204.md) | [0.0 d](/filings/0000821026-26-000010.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [34.4](/filings/0000821026-23-000218.md) | [33.6](/filings/0000821026-24-000141.md) | [34.2](/filings/0000821026-24-000185.md) | [34.3](/filings/0000821026-24-000227.md) | [34.2](/filings/0000821026-25-000112.md) | [34.3](/filings/0000821026-25-000150.md) | [34.4](/filings/0000821026-25-000204.md) | [34.3](/filings/0000821026-26-000070.md) | [34.3](/filings/0000821026-26-000122.md) | [34.2](/filings/0000821026-25-000204.md) | [34.2](/filings/0000821026-26-000070.md) | [34.3](/filings/0000821026-26-000122.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,975,570 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000821026-26-000122.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.